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Quality assurance (QA) for medical linear accelerators is indispensable for appropriate cancer 
treatment. Some international organizations and western advanced countries provide QA 
guidelines for linear accelerators. Currently, QA regulations for linear accelerators in Korean 
hospitals specify a system in which each hospital stipulates its independent hospital-based 
protocols for QA procedures (HP_QAPs) and conducts QA based on these HP_QAPs while 
regulatory authorities verify whether items under these HP_QAPs have been performed. 
However, because this regulatory method cannot guarantee the quality of universal treatment,
and QA items with tolerance criteria are different in many hospitals, the presentation of 
standardized QA items and tolerance criteria is essential. In this study, QA items in HP_QAPs 
from various hospitals and those presented by international organizations, such as the 
International Atomic Energy Agency, European Union, and American Association of Physicist in 
Medicine, and western advanced countries, such as the USA, the UK, and Canada, were 
compared. Concordance rates between QA items for linear accelerators that were presented by 
the aforementioned organizations and those currently being implemented in Korean hospitals 
were shown to exhibit a daily QA of 50%, a weekly QA of 22%, a monthly QA of 43%, and an 
2annual QA of 65%, and the overall concordance rates of all QA items were approximately 48%. 
In comparison between QA items being implemented in Korean hospitals and those being 
implemented in western advanced countries, concordance rates were shown to exhibit a daily QA 
of 50%, a weekly QA of 33%, a monthly QA of 60%, and an annual QA of 67%, and the overall 
concordance rate of all QA items were approximately 57%. The results of this study indicate that 
the HP_QAPs currently implemented by Korean hospitals as QA standards for linear accelerators 
used in radiation therapy do not meet international standards. To solve this problem, it is 
necessary to develop national standardized QA items and procedures for linear accelerators. 
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3I. INTRODUCTION
Cancer treatment aims to provide sufficient radiation doses for tumors with minimum doses to 
normal tissues, thereby completely curing cancers or improving the quality of life of patients by 
reducing the volumes of, or suppressing the growth of, lesion tissues. To this end, advanced 
radiotherapy techniques such as intensity-modulated radiation therapy, image-guided radiation therapy, 
and stereotactic radiotherapy have been introduced into radiotherapy using a linear accelerator, which 
is a radiotherapy device, and these advanced radiotherapy techniques require high degrees of precision 
of radiotherapy machines. As a result, these machines should be periodically checked against electric 
malfunction and mechanical failure through quality assurance (QA) for linear accelerators.
The International Atomic Energy Agency (IAEA) presents the items, trial cycle, and tolerance of QA
for linear accelerators [1]. QA procedures are also presented in the European Commission Radiation 
Protection No.91 of the EU and the task group 40 (TG-40) and TG-142 reports of the American 
Association of Physicists in Medicine (AAPM) [2-4]. Not only international organizations but also 
western advanced countries such as the USA and Canada in North America and the UK and
Switzerland in Europe present standardized items, trial cycles, and tolerance levels of QA for linear 
accelerators through reports and papers, and QA teams of individual hospitals autonomously determine 
QA procedures based on the foregoing discussion [5-10]. 
Currently, each hospital in Korea submits hospital-based protocols for QA procedures (HP_QAPs) to 
the Korea Institute of Nuclear Safety (KINS) to be approved for the treatment of patients using linear 
accelerators, and audits are later conducted to evaluate how the determined items are implemented on 
the basis of these HP_QAP items. The items, trial cycles, and tolerance levels of HP_QAPs are 
autonomously set by each hospital based on its QA teams. While international organizations and
western advanced countries present the guideline of QA procedures for linear accelerators, Korea has 
reached no consensus about standardized QA indicators for linear accelerators. Furthermore, the 
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comparison with the present state of QA for linear accelerators overseas.
This study aims to investigate the current status of QA regulations for linear accelerators to be 
conducted through HP_QAPs of 18 hospitals in Korea and analyze common features and differences of 
the HP_QAPs in comparison with QA items for linear accelerators presented by international 
organizations and western advanced countries to obtain data for the development of standardized QA 
indicators for linear accelerators.
II. METHODS AND MATERIALS
The present state of HP_QAPs in Korea was investigated by requesting and collecting HP_QAP data 
submitted by 18 Korean hospitals to the KINS before the introduction of linear accelerator for the 
treatment of patients. The data obtained were then compared with the present state of QA procedures 
for linear accelerators presented by three international organizations— the IAEA, EU, and AAPM— and 
four western advanced countries— the USA, Canada, the UK, and Switzerland.
The present state of HP_QAPs being implemented by the 18 Korean hospitals is listed in Tables 1–4. 
The HP_QAPs were divided into daily QA, weekly QA, monthly QA, and annual QA according to QA 
trial cycles for linear accelerators, and the implementation rates of individual items were set to indicate 
the ratios of hospitals that were implementing QA for linear accelerators for the relevant items to the 18 
hospitals (For example, if six hospitals out of the 18 hospitals conduct inspections for item 1, the 
implementation rate of item 1 is 33%.).
As for the QA procedures for linear accelerators presented by international organizations, handbooks 
and reports issued by the IAEA, EU, and AAPM were referred to in order to set table items, and the 
procedures were divided into daily QA, weekly QA, monthly QA, and annual QA according to QA trial 
cycles for linear accelerators. To set QA procedures for linear accelerators presented by international 
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AAPM— were collected, and a table was constructed.
The QA procedures for linear accelerators presented by western advanced countries were set on the 
basis of those implemented in the USA and Canada in North America and the UK and Switzerland in 
Europe. The QA procedures for linear accelerators were divided into daily QA, weekly QA, monthly 
QA, and annual QA according to QA trial cycles for linear accelerators, and a table of QA procedures 
for linear accelerators presented by western advanced countries based on QA items presented by at 
least two of the four countries was constructed.
To compare the present state of QA procedures for linear accelerators followed overseas with that of 
HP_QAPs in Korea, hospital-independent QA regulations for linear accelerators in Korea vs. QA 
procedures for linear accelerators by international organizations were compared, as well as hospital-
independent QA regulations for linear accelerators in Korea vs. QA procedure for linear accelerators in 
western advanced countries. The results were indicated as items, tolerance levels, and implementation 
rates, which are the ratios of items being commonly implemented in the HP_QAPs in Korean hospitals 
to QA procedure items for linear accelerators followed overseas.
III. RESULTS AND DISCUSSION
Tables 5–8 show the results of the comparison between the present state of QA procedures for linear 
accelerators presented by international organizations with that of HP_QAPs in Korea. The “0%”in 
execution rate means that the corresponding item is not included in the HP_QAPs of surveyed18 hospitals in 
Korea. Among eight daily QA items for linear accelerators presented by international organizations, 
five were being implemented as HP_QAP items in at least one hospital in Korea, while four were being 
implemented as HP_QAP items in the majority of hospitals in Korea, which showed an implementation 
rate exceeding 50%. In the case of weekly QA, among nine items presented by international 
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two were being implemented as HP_QAP items in the majority of hospitals in Korea, which showed a 
22% implementation rate. A total of 22 monthly QA items for linear accelerators were recommended 
by international organizations; sixteen of them were being implemented as HP_QAP items in at least 
one hospital in Korea, while four were being implemented as HP_QAP items in the majority of 
hospitals in Korea, which showed a 43% implementation rate. Finally, in the case of annual QA, among 
20 items presented by international organizations, 17 were being implemented as HP_QAP items in at 
least one hospital in Korea, while 13 were being implemented as HP_QAP items in the majority of 
hospitals in Korea, showing an implementation rate exceeding 65%. 
Tables 9–12 show the results of comparison between the present state of QA procedures for linear 
accelerators presented by western advanced countries and that of HP_QAPs in Korea. A total of 10 
daily QA items for linear accelerators were presented by western advanced countries; six of them were 
being implemented as HP_QAP items in at least one hospital in Korea, while five were being 
implemented as HP_QAP items in the majority of hospitals in Korea, which showed an implementation 
rate exceeding 50%. In the case of weekly QA, among six items presented by western advanced 
countries, two were being implemented as HP_QAP items in at least one hospital in Korea, and two 
were also being implemented as HP_QAP items in the majority of hospitals in Korea, which showed an 
implementation rate of 33%. Among 20 monthly QA items for linear accelerators presented by western 
advanced countries, 16 were being implemented as HP_QAP items in at least one hospital in Korea, 
while 12 were being implemented as HP_QAP items in the majority of hospitals in Korea, which 
showed an implementation rate of 60%. In the case of annual QA, among 18 items presented by 
western advanced countries, 16 were being implemented as HP_QAP items in at least one hospital in 
Korea, while 12 were being implemented as HP_QAP items in the majority of hospitals in Korea, 
which showed an implementation rate exceeding 67%. 
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and those being implemented in Korea, a total of 58 QA items for linear accelerators were presented by
international organizations; of these items, 28 were being implemented as HP_QAP items in the 
majority of hospitals in Korea, which showed a 48% implementation rate. To compare all the HP_QAP 
items presented by western advanced countries and those being implemented in Korea, a total of 54 QA 
items for linear accelerators were presented by western advanced countries; of these items, 31 were 
being implemented as HP_QAP items in the majority of hospitals in Korea, which showed a 57% 
implementation rate. On comparison of HP_QAPs being implemented by hospitals in Korea with QA 
procedures for linear accelerators presented by international organizations and western advanced 
countries by the foregoing results, HP_QAPs being implemented by the majority of hospitals in Korea
showed an approximately 50% implementation rate, indicating that HP_QAPs implementation in Korea 
should be commended.
In addition, on reviewing the results of the comparison between HP_QAPs being implemented by 
hospitals in Korea and QA procedures for linear accelerators presented by international organizations 
and western advanced countries, compared with those of daily, monthly, and annual QA, the 
implementation rates of weekly QA were lower with 22% and 33% of the QA procedures for linear 
accelerators presented by international organizations and western advanced countries, respectively. 
This can be attributed to the fact that the QA procedures for linear accelerators presented by the 
AAPM’s TG-142 report did not specify weekly QA, and it can be inferred that QA procedures for 
linear accelerators in hospitals in Korea were intensively established with reference to the TG report by 
the AAPM [2-3].
On reviewing the numbers of monthly QA items in the HP_QAPs collected from the 18 hospitals, 
the numbers were diverse by hospital ranging from a minimum of 12 to a maximum of 27. This 
diversity in HP_QAPs in Korea is attributable to the fact that HP_QAPs used as reference data for 
checking radiotherapy in hospitals are autonomously set by QA teams of hospitals. If judged only 
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QA for linear accelerators. However, HP_QAPs involve regulated items submitted to the KINS for 
regulation and can be different from the QA for linear accelerators actually implemented by hospitals. 
QA for linear accelerators is flexibly implemented depending on situations, and more various items of
QA for linear accelerators can be implemented than HP_QAP items.
Because of the nature of HP_QAPs for which regulated items are to be autonomously determined, 
there is always a possibility to implement fewer QA items, as compared with all the QA items, to be set 
as HP_QAP items for reducing the number of items under regulation. Of course, there is no problem if 
the number of HP_QAP items is small; however, the actual QA for linear accelerators is implemented 
for more diverse items. However, if QA for linear accelerators is implemented according to the 
minimized HP_QAPs, ideal radiotherapy effects cannot be expected, and this is closely related to 
national health. This problem originates from the lack of national standardized QA procedures and can 
be solved through the development of such QA guidelines.
IV. CONCLUSIONS
In this study, before developing standardized QA procedure guidelines for linear accelerators in 
Korean hospitals, hospital-independent QA regulations for linear accelerators of 18 hospitals in Korea
were collected and analyzed to investigate and compare the present state of QA procedures with that
recommended by international organizations— the IAEA, EU, and AAPM— and western advanced 
countries— the USA and Canada in North America and the UK and Switzerland in Europe. The results 
of this study are considered usable as seed data for the development of standardized Korean QA
guidelines for linear accelerators.
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Table 1. The daily QA procedure of 18 hospitals in Korea 
Procedure Execution rate (%)
Radiation ON/OFF switches 94.1
Beam on indicator 94.1
Door closing safety 94.1
Audiovisual monitors 100.0
Emergency off switches 88.2
Mechanical check (ODI, laser, degree of vacuum, warning light) 64.7
Environmental check of the treatment room (thermometer, barometer, cleaning) 47.1
Light/radiation field coincidence 11.8
Gantry rotational isocenter & gantry angle indicators 5.9
X-ray flatness and symmetry 5.9
Electron flatness and symmetry 5.9
Operational check of MLC 17.6
Operational check of EPID 17.6
X-ray / electron output constancy 47.1
CBCT IC check 5.9
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Table 2. The weekly QA procedure of 18 hospitals in Korea 
Procedure Execution rate (%)
Radiation ON/OFF switches 16.7
Beam on indicator 16.7
Door closing safety 16.7
Audiovisual monitors 16.7
Emergency off switches 16.7
Gantry angle indicators 83.3
Collimator angle indicators 100.0
Couch angle indicators 100.0
Couch travel in all directions 16.7
ODI test 50.0
Accessory Tray 16.7
Light field size indicator 66.7
Laser localization 50.0
Operational check of MLC 16.7
X-ray output constancy 83.3
Electron output constancy 83.3
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Table 3. The monthly QA procedure of 18 hospitals in Korea 
Procedure Execution rate (%)
Emergency off switches 61.1
Radiation ON/OFF switches 27.8
Beam on indicator 22.2
Door closing safety 38.9
Audiovisual monitors 27.8
Collimator rotation isocenter and angle indicator 94.4
Collimator angle indicator 5.6
Gantry angle indicator 5.6
Gantry rotation isocenter 94.4
Couch travel in all directions 11.1
Couch rotation isocenter and angle indicator 94.4
Light field rotation isocenter and size indicator 33.3
Light/radiation field coincidence 55.6
Latching of wedges 16.7
ODI test 55.6
Laser localization 50.0
Leaf position accuracy 16.7
Asymmetric Jaw test 27.8
picket Fence test 11.1
X-ray output constancy 83.3
X-ray flatness and symmetry 66.7
X-ray dose rate constancy 16.7
X-ray MU Linearity 5.6
X-ray energy constancy 33.3
Electron output constancy 83.3
Electron flatness and symmetry 66.7
Electron dose rate constancy 11.1
Electron MU Linearity 5.6
Electron energy constancy 38.9
Operational check of EPID 11.1
Backup monitor constancy 5.6
Stability of OBI 11.1
Accuracy of the mechanical location of OBI and kV source 11.1
Coincidence of OBI and kV source axis 11.1
Leakage dose measurement 33.3
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Table 4. The annual QA procedure of 18 hospitals in Korea 
Procedure Execution rate (%)
Emergency off switches 16.7
Radiation ON / OFF switches 16.7
Beam on indicator 16.7
Door closing safety 16.7
Audiovisual monitors 16.7
Collimator rotation isocenter and angle indicators 66.7
Collimator  radiation isocenter 50.0
Collimator leakage 16.7
Collimator Jaw position indicators 16.7
Gantry rotation isocenter and angle indicator 50.0
Gantry angle indicators 16.7
Gantry radiation isocenter 50.0
Couch angle indicators 50.0
Couch horizontality and location 50.0
Table top sag 33.3
Couch rotation isocenter 33.3
Couch radiation isocenter 50.0
Couch motion interlock 33.3
Couch z-axis movement accuracy 50.0
ODI test 33.3
Laser location 16.7
Wedge factor constancy 50.0
Monitor chamber linearity 16.7
Light field size 33.3
Light field divergence and cross-hair centering 16.7
Light/radiation field coincidence 33.3
Asymmetric Jaw position indicators 50.0
X-ray output constancy 16.7
X-ray energy constancy 100.0
X-ray dose correction 16.7
X-ray short-term and long term output constancy 16.7
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X-ray dose rate output constancy 50.0
X-ray gantry angle output constancy 50.0
X-ray flatness and symmetry 83.3
X-ray FWHM test 33.3
X-ray output constancy with field size 50.0
X-ray transmission factor of wedge and accessary 33.3
X-ray MU linearity 50.0
Electron output constancy 16.7
Electron energy constancy 83.3
Electron dose correction 16.7
Electron applicator interlock 16.7
Electron output constancy with applicators 50.0
Electron flatness and symmetry 83.3
Electron short-term and long term output constancy 16.7
Electron dose rate output constancy 33.3
Electron output constancy with gantry angle 50.0
Electron FWHM test 33.3
Electron MU linearity 50.0
End effect check 33.3
Independence dose rate test 16.7
Leakage dose measurement 16.7
TPS data reconfirm 16.7
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Table 5. The comparison between the present state of QA procedures for linear accelerators presented 
by international organizations with that of HP_QAPs in Korea (daily QA)
Procedure Tolerance
Execution rate of the 
international organization (%)
Execution rate of the 
hospital in Korea (%)
X-ray output constancy 3% 100 0
Electron output constancy 3% 100 0
Localizing lasers 2 mm 100 64.7
Optical distance indicator (ODI) 2 mm 100 64.7
Door interlock Functional 100 94.1
Audiovisual monitor Functional 100 100
Field size indicator 2 mm 66.7 11.8
Record Performance 66.7 0
16
Table 6. The comparison between the present state of QA procedures for linear accelerators presented 
by international organizations with that of HP_QAPs in Korea (weekly QA)
Procedure Tolerance
Execution rate of the 
international 
organization (%)
Execution rate of the 
hospital in Korea (%)
X-ray output constancy 2% 100 83.3
Electron output constancy 2% 100 83.3
Backup monitor constancy 2% 66.7 0
X-ray central axis dosimetry
parameter constancy (PDD, TAR, 
TPR)
2% 66.7 0
Electron central axis dosimetry 
parameter constancy (PDD)
2 mm @ 
therapeutic depth
66.7 0
X-ray beam flatness constancy 2% 100 0
Electron beam flatness constancy 3% 100 0
Wedge factor constancy 3% 66.7 16.7
Emergency off switches Functional 66.7 16.7
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Table 7. The comparison between the present state of QA procedures for linear accelerators presented 
by international organizations with that of HP_QAPs in Korea (monthly QA)
Procedure Tolerance
Execution rate of the 
international organization(%)
Execution rate of the 
hospital in Korea (%)
X-ray output constancy 2% 100 83.3
Electron output constancy 2% 100 83.3
Backup monitor constancy 2% 66.7 0
X-ray central axis dosimetry parameter 
constancy (PDD, TAR, TPR) 2% 100 33.3
Electron central axis dosimetry 
parameter constancy (PDD)
2 mm @ 
therapeutic 
depth
100 33.3
X-ray beam flatness constancy 2% 66.7 66.7
Electron beam flatness constancy 3% 66.7 66.7
X-ray and electron symmetry 3% 66.7 66.7
Emergency off switches Functional 100 61.1
Wedge, electron cone interlocks Functional 66.7 61.1
Light / radiation field coincidence 2 mm 100 55.6
Gantry / collimator angle indicators 1 ˚ 100 94.4
Wedge position 2 mm 66.7 0
Tray position 2 mm 100 0
Applicator position 2 mm 66.7 0
Field size indicators 2 mm 100 33.3
Cross-hair centering 2 mmdiameter 100 0
Treatment couch position indicators 2 mm / 1˚ 66.7 11.1
Latching of wedges, blocking tray Functional 66.7 16.7
Jaw symmetry 2 mm 66.7 27.8
Field light intensity Functional 66.7 0
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Table 8. The comparison between the present state of QA procedures for linear accelerators presented 
by international organizations with that of HP_QAPs in Korea (annual QA)
Procedure Tolerance
Execution rate of 
the international 
organization(%)
Execution rate 
of the hospital in 
Korea (%)
X-ray / electron output calibration constancy
2%
100 50
Field size dependence of X-ray output 
constancy
2%
66.7 50
Output factor constancy for electron applicators
2%
100 50
Central axis parameter constancy (PDD, TAR)
2%
100 100
Off-axis factor constancy
2%
66.7 0
Transmission factor constancy for all treatment 
accessories
2%
66.7 16.7
Wedge transmission factor constancy
2%
66.7 50
Monitor chamber linearity
1%
66.7 16.7
X-ray output constancy vs gantry angle
2%
66.7 50
Electron output constancy vs gantry angle
2%
66.7 50
Off-axis factor constancy vs gantry angle
2%
66.7 0
Arc mode
1% from baseline
66.7 0
Safety interlocks
Functional
66.7 16.7
Collimator rotation isocenter
2 mm diameter
100 50
Gantry rotation isocenter 2 mm diameter 100 50
Table rotation isocenter 2 mm diameter 100 50
Coincidence of collimator, gantry and table axis 
with the isocenter
2 mm diameter
100 50
Coincidence of radiation and mechanical 
isocenter
2 mm diameter
66.7 50
Table top sag
2 mm
66.7 33.3
Vertical travel of table
2 mm
66.7 50
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Table 9. The comparison between the present state of QA procedures for linear accelerators presented 
by western advanced countries and that of HP_QAPs in Korea (daily QA)
Procedure Tolerance
Execution rate of the 
developed countries (%)
Execution rate of the 
hospital in Korea (%)
X-ray output constancy 3% 100 0
Electron output constancy 3% 100 0
Localizing lasers 2 mm 100 64.7
Optical distance indicator (ODI) 2 mm 75 64.7
Door interlock Functional 75 94.1
Audiovisual monitor Functional 100 100
Beam status(ON) indicators Functional 75 94.1
Room radiation monitors Functional 50 0
Field size indicator 2 mm 50 11.8
Dynamic wedge factors 2% 50 0
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Table 10. The comparison between the present state of QA procedures for linear accelerators presented 
by western advanced countries and that of HP_QAPs in Korea (weekly QA)
Procedure Tolerance
Execution rate of the 
developed countries (%)
Execution rate of the 
Hospital in Korea (%)
X-ray output constancy 2% 75 83.8
Electron output constancy 2% 75 83.3
X-ray central axis dosimetry parameter 
constancy (PDD, TAR, TPR)
2% 50 0
Electron central axis dosimetry parameter 
constancy (PDD)
2 mm @ 
therapeutic 
depth
50 0
X-ray beam flatness constancy 2% 100 0
Electron beam flatness constancy 3% 100 0
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Table 11. The comparison between the present state of QA procedures for linear accelerators presented 
by western advanced countries and that of HP_QAPs in Korea (monthly QA)
Procedure Tolerance
Execution rate of the 
developed countries (%)
Execution rate of the 
Hospital in Korea (%)
X-ray output constancy 2% 50 83.3
Electron output constancy 2% 50 83.3
X-ray central axis dosimetry parameter 
constancy (PDD, TAR, TPR) 2% 100 33.3
Electron central axis dosimetry 
parameter constancy (PDD)
2 mm @ 
therapeutic depth 100 33.3
X-ray beam flatness constancy 2% 50 66.7
Electron beam flatness constancy 3% 50 66.7
X-ray and electron symmetry 3% 50 66.7
Emergency off switches Functional 75 66.7
Wedge, electron cone interlocks Functional 75 61.1
Light / radiation field coincidence 2 mm 100 55.6
Gantry / collimator angle indicators 1 ˚ 100 94.4
Wedge position 2 mm 50 0
Tray position 2 mm 50 0
Applicator position 2 mm 50 0
Field size indicators 2 mm 100 33.3
Cross-hair centering 2 mm diameter 75 0
Coincidence of collimator, gantry and 
table axis with the isocenter 2 mm diameter 50 94.4
Treatment couch position indicators 2 mm / 1˚ 100 11.1
Couch isocenter 2 mm 50 94.4
Couch angle 1˚ 50 94.4
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Table 12. The comparison between the present state of QA procedures for linear accelerators presented 
by western advanced countries and that of HP_QAPs in Korea (monthly QA)
Procedure Tolerance
Execution rate of the 
developed countries (%)
Execution rate of the 
Hospital in Korea (%)
X-ray / electron output calibration 
constancy
2% 100 50
Field size dependence of X-ray output 
constancy
2% 75 50
Output factor constancy for electron 
applicators
2% 75 50
Central axis parameter constancy 2% 100 100
Off-axis factor constancy 2% 50 0
Transmission factor constancy for all 
treatment accessories
2% 75 16.7
Wedge transmission factor constancy 2% 75 50
Monitor chamber linearity 1% 50 16.7
X-ray output constancy vs gantry angle 2% 75 50
Electron output constancy vs gantry angle 2% 50 50
Beam symmetry reproducibility vs gantry 
angle
3% 50 0
Safety interlocks Functional 50 16.7
Collimator rotation isocenter 2 mm diameter 100 50
Gantry rotation isocenter 2 mm diameter 100 50
Table rotation isocenter 2 mm diameter 100 50
Coincidence of collimator, gantry and table 
axis with the isocenter
2 mm diameter 100 50
Coincidence of radiation and mechanical 
isocenter
2 mm diameter 100 50
Table top sag 2 mm 100 33.3
